| id,condition_family,pre_state_vector_summary,pre_trajectory_summary,intervention,intervention_class,post_state_vector_summary,post_trajectory_summary,observed_change_window,pre_basin_signature,post_basin_signature,transition_pathway_summary,coherence_gain_evidence,shift_class,relapse_watchouts,notes,constraints,gold_checklist | |
| IBSM-T01,metabolic,"A1c 7.6; sleep poor; activity low","Flat then worsening","GLP1 agonist","drug","Weight down; A1c 6.8; nausea; activity mixed","Improves then stalls","6 months","Insulin resistance basin","Lower glycemic load basin with side effect drag","Appetite suppression drives change then tolerability limits adherence","Labs improve but behavior unstable","Partial shift","Stopping drug rebound","Need to classify shift strength","Under 240 words.","pre+post+path+evidence+class" | |
| IBSM-T02,neuroimmune,"PEM present; HRV low","Crashes weekly","Graded exercise escalation","behavioral","Temporary gains then major crash","Boom then bust","3 months","Crash basin","Same basin with destabilization","Overreach increases instability","No durable coherence gain","Negative shift","High relapse risk","Should be flagged as harm pathway","Under 240 words.","pre+post+path+evidence+class" | |